XML 22 R17.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Segment Information
3 Months Ended
Jun. 30, 2011
Segment Information [Abstract]  
Segment Information
12. Segment Information
     We report our operations in two operating segments: McKesson Distribution Solutions and McKesson Technology Solutions. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. We evaluate the performance of our operating segments on a number of measures, including operating profit before interest expense, income taxes and results from discontinued operations. Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows:
                 
    Quarter Ended
June 30,
(In millions)   2011   2010
 
Revenues
               
Distribution Solutions (1)
               
Direct distribution & services
  $ 20,827     $ 18,702  
Sales to customers’ warehouses
    4,891       4,743  
       
Total U.S. pharmaceutical distribution & services
    25,718       23,445  
Canada pharmaceutical distribution & services
    2,729       2,560  
Medical-Surgical distribution & services
    731       686  
       
Total Distribution Solutions
    29,178       26,691  
       
Technology Solutions
               
Services
    630       595  
Software & software systems
    144       135  
Hardware
    28       29  
       
Total Technology Solutions
    802       759  
       
Total
  $ 29,980     $ 27,450  
       
Operating profit
               
Distribution Solutions (2)
  $ 475     $ 505  
Technology Solutions
    100       64  
       
Total
    575       569  
Corporate
    (95 )     (86 )
Interest Expense
    (64 )     (43 )
       
Income Before Income Taxes
  $ 416     $ 440  
       
 
(1)   Revenues derived from services represent less than 2% of this segment’s total revenues for the first quarters of 2012 and 2011.
 
(2)   Operating profit for the first quarter of 2011 includes receipt of $51 million representing our share of a settlement of an antitrust class action lawsuit brought against a drug manufacturer. The settlement was recorded as a reduction to cost of sales within our condensed consolidated statements of operations in our Distribution Solutions segment.